Arkolith/Insider Trading/LACQ/Form 4

Matthews Lane Capital Partners LLC

10% OwnerEnsysce Biosciences, Inc. (LACQ) · full profile →Form 4 · filed Jul 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Grant(A)1.6M$1.00$1.6M1.6M
Jun 30, 2021Disposed to issuer(D)250K—$01.8M
Jun 30, 2021Grant(A)367K$1.00$367K2.0M

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-015899) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML